Title |
Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three‐ and five‐year outcomes
|
---|---|
Published in |
Arthritis & Rheumatism, June 2012
|
DOI | 10.1002/art.34409 |
Pubmed ID | |
Authors |
Cailin H. Sibley, Nikki Plass, Joseph Snow, Edythe A. Wiggs, Carmen C. Brewer, Kelly A. King, Christopher Zalewski, H. Jeffrey Kim, Rachel Bishop, Suvimol Hill, Scott M. Paul, Patrick Kicker, Zachary Phillips, Joseph G. Dolan, Brigitte Widemann, Nalini Jayaprakash, Frank Pucino, Deborah L. Stone, Dawn Chapelle, Christopher Snyder, John A. Butman, Robert Wesley, Raphaela Goldbach‐Mansky |
Abstract |
Blocking interleukin-1 with anakinra in patients with the autoinflammatory syndrome neonatal-onset multisystem inflammatory disease (NOMID) reduces systemic and organ-specific inflammation. However, the impact of long-term treatment has not been established. This study was undertaken to evaluate the long-term effect of anakinra on clinical and laboratory outcomes and safety in patients with NOMID. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Israel | 1 | <1% |
Unknown | 154 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 20 | 13% |
Student > Master | 18 | 12% |
Researcher | 17 | 11% |
Student > Ph. D. Student | 17 | 11% |
Student > Doctoral Student | 16 | 10% |
Other | 34 | 22% |
Unknown | 34 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 62 | 40% |
Nursing and Health Professions | 15 | 10% |
Immunology and Microbiology | 7 | 4% |
Agricultural and Biological Sciences | 6 | 4% |
Psychology | 4 | 3% |
Other | 20 | 13% |
Unknown | 42 | 27% |